Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-10 | 2020-05-29 | 111823 |
| TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-10 | 2020-06-04 | 111826 |
| NOVO-GESIC FORTE | 500MG | TABLET | Resolved | 2020-04-10 | 2020-06-04 | 111829 |
| TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2020-04-10 | 2020-04-23 | 111832 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2020-04-10 | 2020-05-21 | 111835 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-04-10 | 2020-10-22 | 111838 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-04-10 | 2020-04-23 | 111841 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2020-04-10 | 2020-09-03 | 111846 |
| TEVA-TOPILENE | 0.05% | CREAM | Resolved | 2020-04-10 | 2020-04-23 | 111851 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2020-04-10 | 2020-04-23 | 111854 |
| TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 2MG 0.035MG | TABLET | Resolved | 2020-04-10 | 2020-05-29 | 111857 |
| TEVA-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2020-04-10 | 2021-04-15 | 111862 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-04-10 | 2021-03-04 | 111865 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Resolved | 2020-04-10 | 2020-05-08 | 111868 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2020-04-10 | 2023-10-03 | 111874 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 3G 0.375G | POWDER FOR SOLUTION | Resolved | 2020-04-10 | 2023-10-04 | 111877 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2020-04-16 | 2020-05-08 | 112364 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2020-04-16 | 2020-04-23 | 112367 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 600MG 200MG 300MG | TABLET | Resolved | 2020-04-16 | 2020-05-08 | 112370 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2020-04-16 | 2020-06-04 | 112373 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |